AMD/RETINA

Long-term aflibercept injection achieve visual improvement and reduced the thickness of the retina and choroid in patients with neovascular age-related macular degeneration (nAMD), according to a study published in BMC Ophthalmology.

In this prospective study, 49 patients (50 eyes) with treatment-naïve nAMD received intravitreal aflibercept injection every 2 months for the first year before switching to a treat-and-extend approach in the subsequent 2 years.…


View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. May 14, 2020

ASRS Annual Meeting to be Held Virtually

The American Society of Retina Specialists (ASRS) will hold its annual meeting online from July 24-26, 2020.

In a letter to ASRS members, Timothy Murray, MD, MBA, ASRS…

Journal Scan

  1. Jul 14, 2020

Visual acuity improvement after aflibercept injection maintained over 3 years

Long-term aflibercept injection achieve visual improvement and reduced the thickness of the retina and choroid in patients with neovascular age-related macular degeneration (nAMD), according to a study published in BMC Ophthalmology.